BRTX (BioRestorative Therapies) ROCE %: -800.95% (As of Mar. 2026)


BRTX BioRestorative Therapies Inc BRTX
51 GF Score
Price $0.38
GF Value $1.52
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BioRestorative Therapies ROCE %?

BioRestorative Therapies BRTX -0.58% 51 ROCE % is -800.95% as of Mar. 2026. GuruFocus rates BRTX with a GF Score™ of 51/100 and a GF Value™ of $1.52 (Possible Value Trap). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BioRestorative Therapies's annualized ROCE % for the quarter that ended in Mar. 2026 was -800.95%.

BioRestorative Therapies  (NAS:BRTX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BioRestorative Therapies ROCE % Related Terms

BioRestorative Therapies ROCE % Historical Data

* Premium members only.

The historical data trend for BioRestorative Therapies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioRestorative Therapies ROCE % Chart

BioRestorative Therapies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -207.22 -115.94 -147.98 -124.67 -352.05

BioRestorative Therapies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -262.07 -240.56 -420.70 -1,193.45 -800.95
BRTX
51GF Score
BioRestorative Therapies Inc BRTX
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioRestorative Therapies ROCE % Calculation

BioRestorative Therapies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-15.647/( ( (12.28 - 3.748) + (4.08 - 3.723) )/ 2 )
=-15.647/( (8.532+0.357)/ 2 )
=-15.647/4.4445
=-352.05 %

BioRestorative Therapies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-13.544/( ( (4.08 - 3.723) + (4.64 - 1.615) )/ 2 )
=-13.544/( ( 0.357 + 3.025 )/ 2 )
=-13.544/1.691
=-800.95 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -800.95% mean?
BioRestorative Therapies (BRTX) has a ROCE % of -800.95% as of Mar. 2026.
Is BioRestorative Therapies' ROCE % too high?
BioRestorative Therapies' current ROCE % is -800.95%. Overall, BioRestorative Therapies has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioRestorative Therapies' ROCE % compare to CVKD and JSPR?
BioRestorative Therapies' ROCE % of -800.95% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. BioRestorative Therapies's current ROCE % is -800.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioRestorative Therapies stock overvalued right now?
Based on GuruFocus' analysis, BioRestorative Therapies (BRTX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.52, compared to a current price of $0.38 — trading 75.3% below its estimated fair value. The current ROCE % is -800.95%. BioRestorative Therapies' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For BioRestorative Therapies (BRTX), the current ROCE % is -800.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioRestorative Therapies (BRTX) Overvalued in 2026?

Based on GuruFocus' analysis, BioRestorative Therapies stock appears to be undervalued. The current stock price of $0.38 is trading 75.3% below its estimated GF Value™ of $1.52. GuruFocus considers BioRestorative Therapies to be Possible Value Trap.

Key valuation signals for BRTX:

  • ROCE %: -800.95%
  • GF Value™: $1.52 vs. price of $0.38 (75.3% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the BRTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioRestorative Therapies Business Description

Other Exchanges 9OF:Germany
Address 40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
51GF Score

Get the complete analysis for BRTX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.38
Price
$1.52
GF Value